Table 1 Baseline characteristics of the patients
Control group (n = 150) | Intervention group (n = 162) | p value | |
|---|---|---|---|
Age, average (SD) | 66.27 (17.9) | 64.72 (18.7) | 0.46 |
Sex, n (%) | 0.86 | ||
Male | 95 (63.3) | 101 (62.3) | |
Female | 55 (36.7) | 61 (37.7) | |
Comorbidities, n (%) | |||
Liver disease | 4 (2.7) | 4 (2.5) | 1.00 |
Heart disease | 38 (25.3) | 39 (24.1) | 0.80 |
Congestive heart failure | 14 (9.3) | 12 (7.4) | 0.54 |
Cerebrovascular disease | 16 (10.7) | 9 (5.6) | 0.10 |
Kidney disease | 12 (8.0) | 12 (7.4) | 0.84 |
COPD | 21 (14) | 27 (16.7) | 0.51 |
Diabetes mellitus | 25 (16.7) | 21 (12.0) | 0.36 |
Charlson Index, median (IQR) | 1 (0–2) | 1 (0–2) | 0.35 |
Charlson Index, categorized, n (%) | 0.40 | ||
0 | 61 (40.7) | 70 (43.2) | |
1 | 37 (24.7) | 47 (29.0) | |
> 1 | 52 (34.7) | 45 (27.8) | |
Categorized PSI, n (%) | 0.51 | ||
I-III | 89 (59.3) | 102 (63) | |
IV-V | 61 (40.7) | 60 (37.0) | |
PSI, average (SD) | 83.7 (33.7) | 81.8 (33.8) | 0.63 |